Secondary Medical Use Part II: Developing Strategies for Enforcement

October 16, 2018 2:15pm

Guido Pontremoli
Corporate IP Patent Director
Chiesi Farmaceutici

Dr Philipp Cepl
Partner
DLA Piper

Nicolas Ruiz
Head of IP
Esteve

Arvid van Oorschot
Partner
Vondst Advocaten N.V.

  • Understanding the scope of secondary medical use patents
  • Enforcing a secondary medical use patent: a view from key stakeholders:
    • Patentees
    • Generic Pharmaceutical companies
    • Biosimilar companies
  • Discussing implications and consequences of failing to file a secondary medical use patent in time.